Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.53 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.49 |
| ▸ | GLA | P06280 | 4/20 | 0.49 |
| ▸ | CASP1 | P29466 | 3/20 | 0.49 |
| ▸ | CASP7 | P55210 | 3/20 | 0.49 |
| ▸ | ATM | Q13315 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29577443 | 1.00 | SRC (0.53) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL8054975 | 0.90 | PSMB8 (0.62) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL29385493 | 0.88 | KDM4E (0.57) | PSMB8PSMB5KDM4EMAPTRAB9A | |
| SCHEMBL593432 | 0.88 | KDM4E (0.57) | PSMB8PSMB5KDM4EMAPTRAB9A | |
| SCHEMBL1264617 | 0.85 | SRC (0.46) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL17941700 | 0.85 | KDM4E (0.58) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL19465287 | 0.85 | SRC (0.46) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL5273872 | 0.84 | PSMB8 (0.51) | PSMB8PSMB5KDM4EMAPTRAB9A | |
| SCHEMBL1518388 | 0.84 | SRC (0.44) | SRCPSMB8PSMB5KDM4EMAPT | |
| SCHEMBL22030047 | 0.84 | PSMB8 (0.54) | PSMB8PSMB5KDM4EMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1173481-B1 | INACTIVATED CYTOKINES FOR IMMUNISATION | NEOVACS (FR) | 2008-11-26 | — | — | EP | claimed |
| US-20050180950-A1 | Chemically modified TNF-alpha | NEOVACS (FR) | 2005-08-18 | — | — | US | claimed |
| EP-1173481-A1 | INACTIVATED CYTOKINES FOR IMMUNISATION | NEOVACS (FR) | 2002-01-23 | — | — | EP | claimed |
| WO-2000064937-A1 | INACTIVATED CYTOKINES FOR IMMUNISATION | NEOVACS (FR) | 2000-11-02 | — | — | WO | claimed |
| US-5652093-A | Analogues of reporter groups as background reducers in binding assays | APROGENEX, INC. (US) | 1997-07-29 | — | — | US | claimed |
| US-5501952-A | Analogues of reporter groups as background reducers in hybridization assays | APROGENEX, INC. (US) | 1996-03-26 | — | — | US | claimed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | claimed |
| US-20260132459-A1 | COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID NANOSTRUCTURES USING COMPACTION OLIGONUCLEOTIDES | ELEMENT BIOSCIENCES INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260132442-A1 | SPATIALLY RESOLVED SURFACE CAPTURE OF NUCLEIC ACIDS | ELEMENT BIOSCIENCES INC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4739794-A1 | METHODS, COMPOSITONS, AND SYSTEMS FOR ANALYTE DETECTION | Stellaromics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260125743-A1 | COMPOSITIONS AND METHODS FOR TARGET DETECTION | STELLAROMICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260125751-A1 | CYANINE DERIVATIVES AND RELATED USES | ELEMENT BIOSCIENCES INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260125671-A1 | METHODS FOR GENERATING CIRCULAR NUCLEIC ACID MOLECULES | ELEMENT BIOSCIENCES INC (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2000064937-A1 | INACTIVATED CYTOKINES FOR IMMUNISATION | NEOVACS (FR) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000018962-A9 | METHODS AND COMPOSITIONS FOR AMPLIFYING DETECTABLE SIGNALS IN SPECIFIC BINDING ASSAYS | AFFYMETRIX INC (US) | 2000-08-24 | — | — | WO | disclosed |
| EP-0999285-A1 | Methods and compositions for amplifying detectable signals in specific binding assays | Affymetrix, Inc. (a California Corporation) (US) | 2000-05-10 | — | — | EP | disclosed |
| US-5652093-A | Analogues of reporter groups as background reducers in binding assays | APROGENEX, INC. (US) | 1997-07-29 | — | — | US | disclosed |
| US-5501952-A | Analogues of reporter groups as background reducers in hybridization assays | APROGENEX, INC. (US) | 1996-03-26 | — | — | US | disclosed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | disclosed |
| US-5376531-A | Detecting gastrointestinal tumor by contacting the sampling with an octasaccharide, measuring by enzyme-linked immunosorbent assays | NORTHWESTERN UNIVERSITY (US) | 1994-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125743-A1 | COMPOSITIONS AND METHODS FOR TARGET DETECTION | SPPL2B, SPPL2A, SRMS | SRC 287/4885PSMB8 4128/4885PSMB5 3645/4885 |
| US-20260125671-A1 | METHODS FOR GENERATING CIRCULAR NUCLEIC ACID MOLECULES | POLM, DNMT3A, POLRMT | SRC 1502/4885PSMB8 1596/4885PSMB5 3073/4885 |
| US-20260125751-A1 | CYANINE DERIVATIVES AND RELATED USES | NSUN2, NSUN3, AS3MT | SRC 997/4885PSMB8 4436/4885PSMB5 4408/4885 |
| US-20260132442-A1 | SPATIALLY RESOLVED SURFACE CAPTURE OF NUCLEIC ACIDS | POLM, RNGTT, CPSF6 | SRC 2744/4885PSMB8 1848/4885PSMB5 3306/4885 |
| US-20260132459-A1 | COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID NANOSTRUCTURES USING COMPACTION OLIGONUCLEOTIDES | PCNA, POLM, RNGTT | SRC 343/4885PSMB8 3478/4885PSMB5 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.